Comments
Commented by Nico Popp on October 22nd, 2025 | 07:10 CEST
Hype and day-to-day business – What matters now: European Lithium, BMW, Mercedes-Benz
European Lithium shares have recently caused quite a stir. But what is behind the surge that has multiplied its value within just a few days? What role does the Company actually play - for the US and also for Europe? We sort through the many reports on European Lithium and show where the Company could be headed in the medium term. One thing seems certain: Without European Lithium, the outlook for the automotive industry on both sides of the Atlantic looks bleak. Reason enough to take a closer look at the background.
Read
Commented by Armin Schulz on October 22nd, 2025 | 07:05 CEST
Bitcoin soars: How Strategy, Nakiki, and BlackRock are benefiting from the new MiCA regulation on tokenization
Bitcoin is reaching new record highs. The hashrate is exploding, and analysts are predicting prices of USD 250,000. At the same time, the EU is establishing clear rules for tokenization through MiCA. This unique combination of technological strength and regulatory clarity is unleashing unprecedented institutional interest. Three companies are strategically positioned to capitalize on this boom: Strategy, Nakiki, and BlackRock. Here, we take a closer look at how these companies have positioned themselves.
Read
Commented by Nico Popp on October 22nd, 2025 | 07:00 CEST
Important piece of the puzzle in the fight against cancer: Vidac Pharma, Roche, Merck & Co.
The pharmaceutical market is enormous - and continues to grow. Market research institute Evaluate forecasts an increase to around USD 1.7 trillion by 2030, representing an annual growth rate of 7.7%. Oncology promises the highest sales, at around USD 300 billion. However, there is no single approach. Instead, new modalities and technologies such as antibody-drug conjugates (ADCs), cell and gene therapies, and radiopharmaceuticals are transforming the industry and gaining significant traction. One thing is clear: progress in the biotech sector is increasingly achieved through the combination of active ingredients and technologies. What role does the biotech company Vidac Pharma play in this?
Read
Commented by André Will-Laudien on October 22nd, 2025 | 06:55 CEST
NEO Battery Materials – Batteries as the key to technological sovereignty
The situation sounds challenging! The global energy transition and the rise of autonomous systems are driving demand for high-performance batteries to historic highs. However, the dependence of Western industries on Chinese supply chains remains a geopolitical risk factor of the first order. In this tense environment, NEO Battery Materials Ltd. (NBM) is positioning itself as North America's hope for the development of cost-efficient, silicon-enhanced lithium-ion batteries. One of the newcomer's great strengths is its combination of modern and efficient materials science, cell architecture, and process optimization into an integrated solution. The focus is on establishing an independent value chain in North America. Time is of the essence, and the barrier to entry is high! Why are investors and producers lining up now?
Read
Commented by André Will-Laudien on October 21st, 2025 | 07:45 CEST
AI boom and DAX fireworks! Another 100% with NetraMark, Bayer, and Novo Nordisk
Savvy investors are already taking notice! Artificial intelligence is revolutionizing drug research and radically reducing development costs. Algorithms are discovering molecular patterns that even the most experienced researchers would overlook, thus accelerating the path from laboratory to patient. Whether in oncology, rare diseases, or metabolic disorders, big data-driven models now enable more precise drug predictions and more realistic simulations of clinical outcomes. Those who understand AI can profit handsomely from the next biotech boom. You just have to muster the courage to finally get involved!
Read
Commented by Carsten Mainitz on October 21st, 2025 | 07:40 CEST
Power Metallic Mines, RENK, BYD – An explosive combination! And the winners are?
Many topics are dominating the headlines. Peace in Gaza – and soon in Ukraine? This prospect initially put a significant damper on defense stocks – but only temporarily. After just a few days of correction, prices are already rising again. Gold at an all-time high is another major topic being covered in the media. Meanwhile, the geopolitical shifts we were reluctant to acknowledge for far too long are now catching up with many companies: China is cutting the world off from critical raw materials and rare earths. Read here to find out how investors can identify promising high-potential opportunities in this constellation.
Read
Commented by André Will-Laudien on October 21st, 2025 | 07:35 CEST
Gold USD 4,300 and Silver USD 53 – Buying frenzy at Silver North, First Majestic, Nel ASA, and JinkoSolar
Silver has been shorted by many investment banks for several years because sufficient supply was available from Mexico and other producing countries. The tide has turned. Over the past 12 months, the precious metal has caught up with its big brother gold, gaining 54%. There are several reasons for the scarcity-driven rally: there are only around 250 active silver mines worldwide, compared to around 1,400 gold mines. In addition, silver has massively expanded its importance as an industrial metal: it is indispensable in high-tech, e-mobility, defense, and medical technology. As a result, less and less physical silver is available to investors, while inventories on the futures markets continue to decline. Now is the time to take a position in silver. Alongside industry giants such as First Majestic, Silver North is among the most promising beneficiaries of the new silver boom.
Read
Commented by Fabian Lorenz on October 21st, 2025 | 07:30 CEST
Raw materials alert for defense and technology! Almonty, MP Materials, and Rheinmetall!
Europe faces a growing raw materials challenge. Whether it is rare earths, tungsten, or other critical metals, these resources are essential not only for defense, but for countless industries, including AI. The FAZ recently spoke to Almonty CEO Lewis Black about this, dedicating almost an entire page to the issue. Conclusion: Europe must act. The US has long since taken decisive action, securing access for its industry by investing in raw materials companies such as MP Materials and Lithium Americas. Europe's hesitation could pose a risk for Rheinmetall, even if investors are currently overlooking it - especially as the Company is also expanding in the US. Hopefully, Defense Minister Pistorius will have this issue on his radar during his visit to Canada.
Read
Commented by Armin Schulz on October 21st, 2025 | 07:25 CEST
Who benefits, who suffers? The raw materials crisis in e-mobility: BYD, Graphano Energy, and Volkswagen
The future of mobility is being decided in the battery factory. Innovative battery cells promise longer ranges and lower costs, but the road to getting there is marked by a fierce race for scarce raw materials and technological supremacy. This tension between disruptive progress and geopolitical risks creates unique opportunities for companies that navigate the transformation strategically. Today, we take a closer look at how BYD, Graphano Energy, and Volkswagen are currently positioning themselves.
Read
Commented by Fabian Lorenz on October 21st, 2025 | 07:20 CEST
SENSATION at DroneShield! Volatus Aerospace enters the AI era! thyssenkrupp rides the TKMS hype!
thyssenkrupp subsidiary TKMS celebrated an impressive stock market debut. On its first day of trading, the share price shot up by over 50%. Fittingly, German Defense Minister Pistorius emphasized investments in the navy during his visit to Atlantic NATO partners. Drone stocks Volatus Aerospace and DroneShield also rose sharply yesterday. The Australian company made headlines with revenue growth of over 1,000%. The outlook for Volatus is also bright – and its valuation remains more conservative.
Read